4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-024943
Director sold 22,845 shares at an average $85.36 ($1,949,996)
- Director disposed of 207,408 shares (other)
- Director acquired 49,663 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-09-09 | Other disposition | −164,162 | 2,074,817 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-09 | Other disposition | −974 | 12,303 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-09 | Other acquisition | +42,272 | 42,272 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-09 | Other disposition | −42,272 | 0 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-09 | Other acquisition | +7,391 | 7,391 | D | ||
| Bolzon Bradley J PhD Director | 2020-09-10 | Sale | −14,161 | $85.03 | $1,204,066 | 540,029 | I |
| Bolzon Bradley J PhD Director | 2020-09-10 | Sale | −8,684 | $85.90 | $745,930 | 531,345 | I |
| Open-market sales · 22,845 sh · avg $85.36 · $1,949,996 | |||||||
Loading xslF345X03/doc4.xml…